Chronic lymphocytic leukaemia: open trials in Denmark

13 open trials have a site in Denmark. Registry data; only the trial team decides who can take part.

2026-525234-39-00
A Phase 1 Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
Trial Treatment · Phase 1 · Janssen Cilag International
Region Midtjylland, Aarhus N · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C
Registry updated 2026-11-06
NCT06588478
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Trial Treatment · Phase 2 · Loxo Oncology, Inc.
Aarhus Universitetshospital, Skejby, Aarhus · Odense Universitetshospital, Odense
Registry updated 2026-11-04
NCT06788509
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C
Registry updated 2026-11-04
NCT06564038
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
Trial Treatment · Phase 1/2 · AstraZeneca
Aalborg University Hospital, Aalborg · Region Midtjylland, Aarhus N · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C
Registry updated 2026-10-28
NCT04728893
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
Aalborg Universitetshospital (Site 0703), Aalborg · Aarhus University Hospital (Site 0702), Aarhus N · Sjællands Universitetshospital Køge (Site 0701), Koege · Odense University Hospital (Site 0705), Odense C
Registry updated 2026-10-27
NCT06943872
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Trial Treatment · Phase 3 · BeOne Medicines
Aalborg University Hospital, Aalborg · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C · Region Sjaelland, Roskilde
Registry updated 2026-10-23
NCT07648264
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Trial Treatment · Phase 3 · CSL Behring
Rigshospitalet, Copenhagen · Zealand University Hospital, Roskilde · Department of Medicine, Vejle Hospital, Vejle
Registry updated 2026-10-14
NCT06136559
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Aalborg University Hospital, Aalborg · Odense University Hospital, Odense C · Region Sjaelland, Roskilde
Registry updated 2026-10-13
NCT07860775
Treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma With Pirtobrutinib in Combination With Epcoritamab if the Disease Comes Back After Previous Treatment.
Trial Treatment · Phase 2 · Stichting Hemato-Oncologie voor Volwassenen Nederland
DK-Copenhagen-RIGSHOSPITALET, Copenhagen
Registry updated 2026-10-06
NCT05791409
Venetoclax Treatment (26 Cycles) With 6 Cycles or 12 Cycles of Epcoritamab in Patients With Relapsed or Refractory CLL or SLL
Trial Treatment · Phase 1/2 · Stichting Hemato-Oncologie voor Volwassenen Nederland
Aalborg University Hospital, Aalborg · Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C
Registry updated 2026-10-05
2023-510294-34-00
A phase 3 multicenter, randomised, prospective, open-label trial of fixed-duration (12 cycles) venetoclax/ obinutuzumab vs. fixed-duration (15 cycles) venetoclax/ pirtobrutinib vs. MRD-guided venetoclax/ pirtobrutinib in patients with previously untreated chronic lymphocytic leukaemia (CLL)/ small lymphocytic lymphoma (SLL) aiming to establish measurement of individual residual disease for adjustment of treatment duration to improve outcomes (CLL18/ MOIRAI)
Trial Treatment · Phase 3 · University Of Cologne
Region Midtjylland, Aarhus N · Rigshospitalet, Copenhagen Oe · Region Sjaelland, Koege · Odense University Hospital, Odense C · Lillebaelt Hospital, Vejle
Registry updated 2026-10-01
NCT06542250
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
Trial Treatment · Phase 1/2 · AstraZeneca
København Ø
Registry updated 2026-09-30
NCT04523428
REtreatment With VEnetoclax and Acalabrutinib After Venetoclax Limited Duration (REVEAL)
Trial Treatment · Phase 2 · Stichting Hemato-Oncologie voor Volwassenen Nederland
Aarhus Universitetshospital, Aarhus N
Registry updated 2026-09-21

All Chronic lymphocytic leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error